0000950170-24-131098.txt : 20241126 0000950170-24-131098.hdr.sgml : 20241126 20241126165831 ACCESSION NUMBER: 0000950170-24-131098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241126 FILED AS OF DATE: 20241126 DATE AS OF CHANGE: 20241126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howe Jill Ann CENTRAL INDEX KEY: 0001892397 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 241505063 MAIL ADDRESS: STREET 1: C/O DTX PHARMA, INC. STREET 2: 10655 SORRENTO VALLEY ROAD, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 4 1 ownership.xml 4 X0508 4 2024-11-26 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001892397 Howe Jill Ann C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 false true false false Chief Financial Officer false Common Shares 2024-11-26 4 P false 15000 0.59 A 25500 D The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5925 to $0.5929, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1. /s/ Jill A. Howe 2024-11-26